http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Fri, 17 Jul 2026 08:30:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/Bayer+and+Henry+Ford+Health+Announce+Strategic+Research+Partnership+to+Expand+Patient+Access+to+Clinical+Trials/26782224.html <p> Henry Ford Health selected as one of only four U.S. academic health systems in Bayer’s strategic research network </p> <p> DETROIT--(BUSINESS WIRE)-- Bayer, a global life sciences company, and Henry Ford Health today announced a strategic partnership to expand clinical trial opportunities for patients. The work brings together Bayer’s global drug development expertise with Henry Ford Health’s comprehensive clinical research program and its deep connection to the communities it serves. </p><p> “Clinical trials are often the first opportunity patients have to access cutting-edge treatments,” said Dr. David Lanfear, Chief Scientific Officer for Henry Ford Health. “Through this collaboration, we aim to make http://www.streetinsider.com/Press+Releases/Bayer+and+Henry+Ford+Health+Announce+Strategic+Research+Partnership+to+Expand+Patient+Access+to+Clinical+Trials/26782224.html Fri, 17 Jul 2026 08:30:00 -0400 BAYN BAYN BAYRY BAYZF O.00258640 http://www.streetinsider.com/Press+Releases/Bayer+and+Henry+Ford+Health+Announce+Strategic+Research+Partnership+to+Expand+Patient+Access+to+Clinical+Trials/26782224.html <p> Henry Ford Health selected as one of only four U.S. academic health systems in Bayer’s strategic research network </p> <p> DETROIT--(BUSINESS WIRE)-- Bayer, a global life sciences company, and Henry Ford Health today announced a strategic partnership to expand clinical trial opportunities for patients. The work brings together Bayer’s global drug development expertise with Henry Ford Health’s comprehensive clinical research program and its deep connection to the communities it serves. </p><p> “Clinical trials are often the first opportunity patients have to access cutting-edge treatments,” said Dr. David Lanfear, Chief Scientific Officer for Henry Ford Health. “Through this collaboration, we aim to make http://www.streetinsider.com/Press+Releases/Bayer+and+Henry+Ford+Health+Announce+Strategic+Research+Partnership+to+Expand+Patient+Access+to+Clinical+Trials/26782224.html Fri, 17 Jul 2026 08:30:00 -0400 BAYN BAYN BAYRY BAYZF O.00258640 http://www.streetinsider.com/Press+Releases/Bayer+and+Henry+Ford+Health+Announce+Strategic+Research+Partnership+to+Expand+Patient+Access+to+Clinical+Trials/26782224.html <p> Henry Ford Health selected as one of only four U.S. academic health systems in Bayer’s strategic research network </p> <p> DETROIT--(BUSINESS WIRE)-- Bayer, a global life sciences company, and Henry Ford Health today announced a strategic partnership to expand clinical trial opportunities for patients. The work brings together Bayer’s global drug development expertise with Henry Ford Health’s comprehensive clinical research program and its deep connection to the communities it serves. </p><p> “Clinical trials are often the first opportunity patients have to access cutting-edge treatments,” said Dr. David Lanfear, Chief Scientific Officer for Henry Ford Health. “Through this collaboration, we aim to make http://www.streetinsider.com/Press+Releases/Bayer+and+Henry+Ford+Health+Announce+Strategic+Research+Partnership+to+Expand+Patient+Access+to+Clinical+Trials/26782224.html Fri, 17 Jul 2026 08:30:00 -0400 BAYN BAYN BAYRY BAYZF O.00258640 http://www.streetinsider.com/Press+Releases/Bayer+and+Henry+Ford+Health+Announce+Strategic+Research+Partnership+to+Expand+Patient+Access+to+Clinical+Trials/26782224.html <p> Henry Ford Health selected as one of only four U.S. academic health systems in Bayer’s strategic research network </p> <p> DETROIT--(BUSINESS WIRE)-- Bayer, a global life sciences company, and Henry Ford Health today announced a strategic partnership to expand clinical trial opportunities for patients. The work brings together Bayer’s global drug development expertise with Henry Ford Health’s comprehensive clinical research program and its deep connection to the communities it serves. </p><p> “Clinical trials are often the first opportunity patients have to access cutting-edge treatments,” said Dr. David Lanfear, Chief Scientific Officer for Henry Ford Health. “Through this collaboration, we aim to make http://www.streetinsider.com/Press+Releases/Bayer+and+Henry+Ford+Health+Announce+Strategic+Research+Partnership+to+Expand+Patient+Access+to+Clinical+Trials/26782224.html Fri, 17 Jul 2026 08:30:00 -0400 BAYN BAYN BAYRY BAYZF O.00258640 http://www.streetinsider.com/Press+Releases/Bayer+and+Henry+Ford+Health+Announce+Strategic+Research+Partnership+to+Expand+Patient+Access+to+Clinical+Trials/26782224.html <p> Henry Ford Health selected as one of only four U.S. academic health systems in Bayer’s strategic research network </p> <p> DETROIT--(BUSINESS WIRE)-- Bayer, a global life sciences company, and Henry Ford Health today announced a strategic partnership to expand clinical trial opportunities for patients. The work brings together Bayer’s global drug development expertise with Henry Ford Health’s comprehensive clinical research program and its deep connection to the communities it serves. </p><p> “Clinical trials are often the first opportunity patients have to access cutting-edge treatments,” said Dr. David Lanfear, Chief Scientific Officer for Henry Ford Health. “Through this collaboration, we aim to make http://www.streetinsider.com/Press+Releases/Bayer+and+Henry+Ford+Health+Announce+Strategic+Research+Partnership+to+Expand+Patient+Access+to+Clinical+Trials/26782224.html Fri, 17 Jul 2026 08:30:00 -0400 BAYN BAYN BAYRY BAYZF O.00258640 http://www.streetinsider.com/Business+Wire/Bayer+and+Henry+Ford+Health+Announce+Strategic+Research+Partnership+to+Expand+Patient+Access+to+Clinical+Trials/26782224.html <p> Henry Ford Health selected as one of only four U.S. academic health systems in Bayer’s strategic research network </p> <p> DETROIT--(BUSINESS WIRE)-- Bayer, a global life sciences company, and Henry Ford Health today announced a strategic partnership to expand clinical trial opportunities for patients. The work brings together Bayer’s global drug development expertise with Henry Ford Health’s comprehensive clinical research program and its deep connection to the communities it serves. </p><p> “Clinical trials are often the first opportunity patients have to access cutting-edge treatments,” said Dr. David Lanfear, Chief Scientific Officer for Henry Ford Health. “Through this collaboration, we aim to make http://www.streetinsider.com/Business+Wire/Bayer+and+Henry+Ford+Health+Announce+Strategic+Research+Partnership+to+Expand+Patient+Access+to+Clinical+Trials/26782224.html Fri, 17 Jul 2026 08:30:00 -0400 BAYN BAYN BAYRY BAYZF O.00258640 http://www.streetinsider.com/Business+Wire/Bayer+and+Henry+Ford+Health+Announce+Strategic+Research+Partnership+to+Expand+Patient+Access+to+Clinical+Trials/26782224.html <p> Henry Ford Health selected as one of only four U.S. academic health systems in Bayer’s strategic research network </p> <p> DETROIT--(BUSINESS WIRE)-- Bayer, a global life sciences company, and Henry Ford Health today announced a strategic partnership to expand clinical trial opportunities for patients. The work brings together Bayer’s global drug development expertise with Henry Ford Health’s comprehensive clinical research program and its deep connection to the communities it serves. </p><p> “Clinical trials are often the first opportunity patients have to access cutting-edge treatments,” said Dr. David Lanfear, Chief Scientific Officer for Henry Ford Health. “Through this collaboration, we aim to make http://www.streetinsider.com/Business+Wire/Bayer+and+Henry+Ford+Health+Announce+Strategic+Research+Partnership+to+Expand+Patient+Access+to+Clinical+Trials/26782224.html Fri, 17 Jul 2026 08:30:00 -0400 BAYN BAYN BAYRY BAYZF O.00258640 http://www.streetinsider.com/Business+Wire/Bayer+and+Henry+Ford+Health+Announce+Strategic+Research+Partnership+to+Expand+Patient+Access+to+Clinical+Trials/26782224.html <p> Henry Ford Health selected as one of only four U.S. academic health systems in Bayer’s strategic research network </p> <p> DETROIT--(BUSINESS WIRE)-- Bayer, a global life sciences company, and Henry Ford Health today announced a strategic partnership to expand clinical trial opportunities for patients. The work brings together Bayer’s global drug development expertise with Henry Ford Health’s comprehensive clinical research program and its deep connection to the communities it serves. </p><p> “Clinical trials are often the first opportunity patients have to access cutting-edge treatments,” said Dr. David Lanfear, Chief Scientific Officer for Henry Ford Health. “Through this collaboration, we aim to make http://www.streetinsider.com/Business+Wire/Bayer+and+Henry+Ford+Health+Announce+Strategic+Research+Partnership+to+Expand+Patient+Access+to+Clinical+Trials/26782224.html Fri, 17 Jul 2026 08:30:00 -0400 BAYN BAYN BAYRY BAYZF O.00258640 http://www.streetinsider.com/Business+Wire/Bayer+and+Henry+Ford+Health+Announce+Strategic+Research+Partnership+to+Expand+Patient+Access+to+Clinical+Trials/26782224.html <p> Henry Ford Health selected as one of only four U.S. academic health systems in Bayer’s strategic research network </p> <p> DETROIT--(BUSINESS WIRE)-- Bayer, a global life sciences company, and Henry Ford Health today announced a strategic partnership to expand clinical trial opportunities for patients. The work brings together Bayer’s global drug development expertise with Henry Ford Health’s comprehensive clinical research program and its deep connection to the communities it serves. </p><p> “Clinical trials are often the first opportunity patients have to access cutting-edge treatments,” said Dr. David Lanfear, Chief Scientific Officer for Henry Ford Health. “Through this collaboration, we aim to make http://www.streetinsider.com/Business+Wire/Bayer+and+Henry+Ford+Health+Announce+Strategic+Research+Partnership+to+Expand+Patient+Access+to+Clinical+Trials/26782224.html Fri, 17 Jul 2026 08:30:00 -0400 BAYN BAYN BAYRY BAYZF O.00258640 http://www.streetinsider.com/Business+Wire/Bayer+and+Henry+Ford+Health+Announce+Strategic+Research+Partnership+to+Expand+Patient+Access+to+Clinical+Trials/26782224.html <p> Henry Ford Health selected as one of only four U.S. academic health systems in Bayer’s strategic research network </p> <p> DETROIT--(BUSINESS WIRE)-- Bayer, a global life sciences company, and Henry Ford Health today announced a strategic partnership to expand clinical trial opportunities for patients. The work brings together Bayer’s global drug development expertise with Henry Ford Health’s comprehensive clinical research program and its deep connection to the communities it serves. </p><p> “Clinical trials are often the first opportunity patients have to access cutting-edge treatments,” said Dr. David Lanfear, Chief Scientific Officer for Henry Ford Health. “Through this collaboration, we aim to make http://www.streetinsider.com/Business+Wire/Bayer+and+Henry+Ford+Health+Announce+Strategic+Research+Partnership+to+Expand+Patient+Access+to+Clinical+Trials/26782224.html Fri, 17 Jul 2026 08:30:00 -0400 BAYN BAYN BAYRY BAYZF O.00258640 http://www.streetinsider.com/Press+Releases/Sabanto+and+Leaps+by+Bayer+Announce+Oversubscribed+Series+B+Financing+to+Scale+Autonomous+Technology+for+Row+Crop+Farming/26765219.html <ul class="bwlistdisc"> <li> Funding supports commercialization and sales growth expansion, targeting hundreds of new farms in the next 12 months </li> <li> Autonomy technology is designed to lower capital expenditures and unlock the ability to scale operations more efficiently </li> <li> Sabanto’s physical AI makes swarm operations possible so that growers can replace horsepower with time </li> </ul> <p> AMES, Iowa--(BUSINESS WIRE)-- Sabanto, a leader in autonomous retrofit technology for agriculture, today announced an oversubscribed Series B funding led by Leaps by Bayer with participation by Sustainable Forward Capital, InnoVenture Iowa, Fulcrum Global Capital, DCVC, and Yara. The round will accelerate broad adoption of autonomous technology, expand customer base, http://www.streetinsider.com/Press+Releases/Sabanto+and+Leaps+by+Bayer+Announce+Oversubscribed+Series+B+Financing+to+Scale+Autonomous+Technology+for+Row+Crop+Farming/26765219.html Tue, 14 Jul 2026 08:10:00 -0400 BAYN BAYN BAYRY BAYZF O.00258640 http://www.streetinsider.com/Press+Releases/Sabanto+and+Leaps+by+Bayer+Announce+Oversubscribed+Series+B+Financing+to+Scale+Autonomous+Technology+for+Row+Crop+Farming/26765219.html <ul class="bwlistdisc"> <li> Funding supports commercialization and sales growth expansion, targeting hundreds of new farms in the next 12 months </li> <li> Autonomy technology is designed to lower capital expenditures and unlock the ability to scale operations more efficiently </li> <li> Sabanto’s physical AI makes swarm operations possible so that growers can replace horsepower with time </li> </ul> <p> AMES, Iowa--(BUSINESS WIRE)-- Sabanto, a leader in autonomous retrofit technology for agriculture, today announced an oversubscribed Series B funding led by Leaps by Bayer with participation by Sustainable Forward Capital, InnoVenture Iowa, Fulcrum Global Capital, DCVC, and Yara. The round will accelerate broad adoption of autonomous technology, expand customer base, http://www.streetinsider.com/Press+Releases/Sabanto+and+Leaps+by+Bayer+Announce+Oversubscribed+Series+B+Financing+to+Scale+Autonomous+Technology+for+Row+Crop+Farming/26765219.html Tue, 14 Jul 2026 08:10:00 -0400 BAYN BAYN BAYRY BAYZF O.00258640 http://www.streetinsider.com/Press+Releases/Sabanto+and+Leaps+by+Bayer+Announce+Oversubscribed+Series+B+Financing+to+Scale+Autonomous+Technology+for+Row+Crop+Farming/26765219.html <ul class="bwlistdisc"> <li> Funding supports commercialization and sales growth expansion, targeting hundreds of new farms in the next 12 months </li> <li> Autonomy technology is designed to lower capital expenditures and unlock the ability to scale operations more efficiently </li> <li> Sabanto’s physical AI makes swarm operations possible so that growers can replace horsepower with time </li> </ul> <p> AMES, Iowa--(BUSINESS WIRE)-- Sabanto, a leader in autonomous retrofit technology for agriculture, today announced an oversubscribed Series B funding led by Leaps by Bayer with participation by Sustainable Forward Capital, InnoVenture Iowa, Fulcrum Global Capital, DCVC, and Yara. The round will accelerate broad adoption of autonomous technology, expand customer base, http://www.streetinsider.com/Press+Releases/Sabanto+and+Leaps+by+Bayer+Announce+Oversubscribed+Series+B+Financing+to+Scale+Autonomous+Technology+for+Row+Crop+Farming/26765219.html Tue, 14 Jul 2026 08:10:00 -0400 BAYN BAYN BAYRY BAYZF O.00258640 http://www.streetinsider.com/Press+Releases/Sabanto+and+Leaps+by+Bayer+Announce+Oversubscribed+Series+B+Financing+to+Scale+Autonomous+Technology+for+Row+Crop+Farming/26765219.html <ul class="bwlistdisc"> <li> Funding supports commercialization and sales growth expansion, targeting hundreds of new farms in the next 12 months </li> <li> Autonomy technology is designed to lower capital expenditures and unlock the ability to scale operations more efficiently </li> <li> Sabanto’s physical AI makes swarm operations possible so that growers can replace horsepower with time </li> </ul> <p> AMES, Iowa--(BUSINESS WIRE)-- Sabanto, a leader in autonomous retrofit technology for agriculture, today announced an oversubscribed Series B funding led by Leaps by Bayer with participation by Sustainable Forward Capital, InnoVenture Iowa, Fulcrum Global Capital, DCVC, and Yara. The round will accelerate broad adoption of autonomous technology, expand customer base, http://www.streetinsider.com/Press+Releases/Sabanto+and+Leaps+by+Bayer+Announce+Oversubscribed+Series+B+Financing+to+Scale+Autonomous+Technology+for+Row+Crop+Farming/26765219.html Tue, 14 Jul 2026 08:10:00 -0400 BAYN BAYN BAYRY BAYZF O.00258640 http://www.streetinsider.com/Press+Releases/Sabanto+and+Leaps+by+Bayer+Announce+Oversubscribed+Series+B+Financing+to+Scale+Autonomous+Technology+for+Row+Crop+Farming/26765219.html <ul class="bwlistdisc"> <li> Funding supports commercialization and sales growth expansion, targeting hundreds of new farms in the next 12 months </li> <li> Autonomy technology is designed to lower capital expenditures and unlock the ability to scale operations more efficiently </li> <li> Sabanto’s physical AI makes swarm operations possible so that growers can replace horsepower with time </li> </ul> <p> AMES, Iowa--(BUSINESS WIRE)-- Sabanto, a leader in autonomous retrofit technology for agriculture, today announced an oversubscribed Series B funding led by Leaps by Bayer with participation by Sustainable Forward Capital, InnoVenture Iowa, Fulcrum Global Capital, DCVC, and Yara. The round will accelerate broad adoption of autonomous technology, expand customer base, http://www.streetinsider.com/Press+Releases/Sabanto+and+Leaps+by+Bayer+Announce+Oversubscribed+Series+B+Financing+to+Scale+Autonomous+Technology+for+Row+Crop+Farming/26765219.html Tue, 14 Jul 2026 08:10:00 -0400 BAYN BAYN BAYRY BAYZF O.00258640 http://www.streetinsider.com/Business+Wire/Sabanto+and+Leaps+by+Bayer+Announce+Oversubscribed+Series+B+Financing+to+Scale+Autonomous+Technology+for+Row+Crop+Farming/26765219.html <ul class="bwlistdisc"> <li> Funding supports commercialization and sales growth expansion, targeting hundreds of new farms in the next 12 months </li> <li> Autonomy technology is designed to lower capital expenditures and unlock the ability to scale operations more efficiently </li> <li> Sabanto’s physical AI makes swarm operations possible so that growers can replace horsepower with time </li> </ul> <p> AMES, Iowa--(BUSINESS WIRE)-- Sabanto, a leader in autonomous retrofit technology for agriculture, today announced an oversubscribed Series B funding led by Leaps by Bayer with participation by Sustainable Forward Capital, InnoVenture Iowa, Fulcrum Global Capital, DCVC, and Yara. The round will accelerate broad adoption of autonomous technology, expand customer base, http://www.streetinsider.com/Business+Wire/Sabanto+and+Leaps+by+Bayer+Announce+Oversubscribed+Series+B+Financing+to+Scale+Autonomous+Technology+for+Row+Crop+Farming/26765219.html Tue, 14 Jul 2026 08:10:00 -0400 BAYN BAYN BAYRY BAYZF O.00258640 http://www.streetinsider.com/Business+Wire/Sabanto+and+Leaps+by+Bayer+Announce+Oversubscribed+Series+B+Financing+to+Scale+Autonomous+Technology+for+Row+Crop+Farming/26765219.html <ul class="bwlistdisc"> <li> Funding supports commercialization and sales growth expansion, targeting hundreds of new farms in the next 12 months </li> <li> Autonomy technology is designed to lower capital expenditures and unlock the ability to scale operations more efficiently </li> <li> Sabanto’s physical AI makes swarm operations possible so that growers can replace horsepower with time </li> </ul> <p> AMES, Iowa--(BUSINESS WIRE)-- Sabanto, a leader in autonomous retrofit technology for agriculture, today announced an oversubscribed Series B funding led by Leaps by Bayer with participation by Sustainable Forward Capital, InnoVenture Iowa, Fulcrum Global Capital, DCVC, and Yara. The round will accelerate broad adoption of autonomous technology, expand customer base, http://www.streetinsider.com/Business+Wire/Sabanto+and+Leaps+by+Bayer+Announce+Oversubscribed+Series+B+Financing+to+Scale+Autonomous+Technology+for+Row+Crop+Farming/26765219.html Tue, 14 Jul 2026 08:10:00 -0400 BAYN BAYN BAYRY BAYZF O.00258640 http://www.streetinsider.com/Business+Wire/Sabanto+and+Leaps+by+Bayer+Announce+Oversubscribed+Series+B+Financing+to+Scale+Autonomous+Technology+for+Row+Crop+Farming/26765219.html <ul class="bwlistdisc"> <li> Funding supports commercialization and sales growth expansion, targeting hundreds of new farms in the next 12 months </li> <li> Autonomy technology is designed to lower capital expenditures and unlock the ability to scale operations more efficiently </li> <li> Sabanto’s physical AI makes swarm operations possible so that growers can replace horsepower with time </li> </ul> <p> AMES, Iowa--(BUSINESS WIRE)-- Sabanto, a leader in autonomous retrofit technology for agriculture, today announced an oversubscribed Series B funding led by Leaps by Bayer with participation by Sustainable Forward Capital, InnoVenture Iowa, Fulcrum Global Capital, DCVC, and Yara. The round will accelerate broad adoption of autonomous technology, expand customer base, http://www.streetinsider.com/Business+Wire/Sabanto+and+Leaps+by+Bayer+Announce+Oversubscribed+Series+B+Financing+to+Scale+Autonomous+Technology+for+Row+Crop+Farming/26765219.html Tue, 14 Jul 2026 08:10:00 -0400 BAYN BAYN BAYRY BAYZF O.00258640 http://www.streetinsider.com/Business+Wire/Sabanto+and+Leaps+by+Bayer+Announce+Oversubscribed+Series+B+Financing+to+Scale+Autonomous+Technology+for+Row+Crop+Farming/26765219.html <ul class="bwlistdisc"> <li> Funding supports commercialization and sales growth expansion, targeting hundreds of new farms in the next 12 months </li> <li> Autonomy technology is designed to lower capital expenditures and unlock the ability to scale operations more efficiently </li> <li> Sabanto’s physical AI makes swarm operations possible so that growers can replace horsepower with time </li> </ul> <p> AMES, Iowa--(BUSINESS WIRE)-- Sabanto, a leader in autonomous retrofit technology for agriculture, today announced an oversubscribed Series B funding led by Leaps by Bayer with participation by Sustainable Forward Capital, InnoVenture Iowa, Fulcrum Global Capital, DCVC, and Yara. The round will accelerate broad adoption of autonomous technology, expand customer base, http://www.streetinsider.com/Business+Wire/Sabanto+and+Leaps+by+Bayer+Announce+Oversubscribed+Series+B+Financing+to+Scale+Autonomous+Technology+for+Row+Crop+Farming/26765219.html Tue, 14 Jul 2026 08:10:00 -0400 BAYN BAYN BAYRY BAYZF O.00258640 http://www.streetinsider.com/Business+Wire/Sabanto+and+Leaps+by+Bayer+Announce+Oversubscribed+Series+B+Financing+to+Scale+Autonomous+Technology+for+Row+Crop+Farming/26765219.html <ul class="bwlistdisc"> <li> Funding supports commercialization and sales growth expansion, targeting hundreds of new farms in the next 12 months </li> <li> Autonomy technology is designed to lower capital expenditures and unlock the ability to scale operations more efficiently </li> <li> Sabanto’s physical AI makes swarm operations possible so that growers can replace horsepower with time </li> </ul> <p> AMES, Iowa--(BUSINESS WIRE)-- Sabanto, a leader in autonomous retrofit technology for agriculture, today announced an oversubscribed Series B funding led by Leaps by Bayer with participation by Sustainable Forward Capital, InnoVenture Iowa, Fulcrum Global Capital, DCVC, and Yara. The round will accelerate broad adoption of autonomous technology, expand customer base, http://www.streetinsider.com/Business+Wire/Sabanto+and+Leaps+by+Bayer+Announce+Oversubscribed+Series+B+Financing+to+Scale+Autonomous+Technology+for+Row+Crop+Farming/26765219.html Tue, 14 Jul 2026 08:10:00 -0400 BAYN BAYN BAYRY BAYZF O.00258640 http://www.streetinsider.com/Press+Releases/The+University+of+Colorado+Anschutz%2C+along+with+UCHealth+and+Children%E2%80%99s+Hospital+Colorado%2C+Form+Strategic+Alliance+with+Bayer+to+Advance+Drug+Development+and+Clinical+Trials/26740099.html <p class="bwalignc"> <i>Bayer’s first academic medical center alliance for clinical trial collaboration is designed to accelerate medical discovery and expand patient access to investigational therapies</i> </p> <p> AURORA, Colo. &amp; WHIPPANY, N.J.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.bayer.com%2Fen%2Fpharma%2Fpharmaceuticals&amp;esheet=54565969&amp;newsitemid=20260707806251&amp;lan=en-US&amp;anchor=Bayer&amp;index=1&amp;md5=3c554759b84e4a37c31cb48405b42861" shape="rect">Bayer</a>, a global life sciences company, has announced a new strategic alliance focused on clinical trials collaboration with <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.cuanschutz.edu%2F&amp;esheet=54565969&amp;newsitemid=20260707806251&amp;lan=en-US&amp;anchor=the+University+of+Colorado+Anschutz&amp;index=2&amp;md5=28722d154de42e09ce8031fd0f123770" shape="rect">the University of Colorado Anschutz</a>, <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.uchealth.org%2F&amp;esheet=54565969&amp;newsitemid=20260707806251&amp;lan=en-US&amp;anchor=UCHealth&amp;index=3&amp;md5=2fcb1924a5e4a4bc281123641aa916f4" shape="rect">UCHealth</a> and <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.childrenscolorado.org%2F&amp;esheet=54565969&amp;newsitemid=20260707806251&amp;lan=en-US&amp;anchor=Children%26%238217%3Bs+Hospital+Colorado&amp;index=4&amp;md5=e2511c6928cd7c67f5eb64ed32077251" shape="rect">Children’s Hospital Colorado</a>, establishing Bayer’s first alliance of its kind with an academic medical center. The initiative reflects a shared commitment to accelerating clinical research through stronger http://www.streetinsider.com/Press+Releases/The+University+of+Colorado+Anschutz%2C+along+with+UCHealth+and+Children%E2%80%99s+Hospital+Colorado%2C+Form+Strategic+Alliance+with+Bayer+to+Advance+Drug+Development+and+Clinical+Trials/26740099.html Tue, 07 Jul 2026 10:00:00 -0400 A.31723490 A.41160441 BAYN BAYN BAYRY BAYZF O.00181262 O.00258640 O.52999085 http://www.streetinsider.com/Press+Releases/The+University+of+Colorado+Anschutz%2C+along+with+UCHealth+and+Children%E2%80%99s+Hospital+Colorado%2C+Form+Strategic+Alliance+with+Bayer+to+Advance+Drug+Development+and+Clinical+Trials/26740099.html <p class="bwalignc"> <i>Bayer’s first academic medical center alliance for clinical trial collaboration is designed to accelerate medical discovery and expand patient access to investigational therapies</i> </p> <p> AURORA, Colo. &amp; WHIPPANY, N.J.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.bayer.com%2Fen%2Fpharma%2Fpharmaceuticals&amp;esheet=54565969&amp;newsitemid=20260707806251&amp;lan=en-US&amp;anchor=Bayer&amp;index=1&amp;md5=3c554759b84e4a37c31cb48405b42861" shape="rect">Bayer</a>, a global life sciences company, has announced a new strategic alliance focused on clinical trials collaboration with <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.cuanschutz.edu%2F&amp;esheet=54565969&amp;newsitemid=20260707806251&amp;lan=en-US&amp;anchor=the+University+of+Colorado+Anschutz&amp;index=2&amp;md5=28722d154de42e09ce8031fd0f123770" shape="rect">the University of Colorado Anschutz</a>, <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.uchealth.org%2F&amp;esheet=54565969&amp;newsitemid=20260707806251&amp;lan=en-US&amp;anchor=UCHealth&amp;index=3&amp;md5=2fcb1924a5e4a4bc281123641aa916f4" shape="rect">UCHealth</a> and <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.childrenscolorado.org%2F&amp;esheet=54565969&amp;newsitemid=20260707806251&amp;lan=en-US&amp;anchor=Children%26%238217%3Bs+Hospital+Colorado&amp;index=4&amp;md5=e2511c6928cd7c67f5eb64ed32077251" shape="rect">Children’s Hospital Colorado</a>, establishing Bayer’s first alliance of its kind with an academic medical center. The initiative reflects a shared commitment to accelerating clinical research through stronger http://www.streetinsider.com/Press+Releases/The+University+of+Colorado+Anschutz%2C+along+with+UCHealth+and+Children%E2%80%99s+Hospital+Colorado%2C+Form+Strategic+Alliance+with+Bayer+to+Advance+Drug+Development+and+Clinical+Trials/26740099.html Tue, 07 Jul 2026 10:00:00 -0400 A.31723490 A.41160441 BAYN BAYN BAYRY BAYZF O.00181262 O.00258640 O.52999085 http://www.streetinsider.com/Press+Releases/The+University+of+Colorado+Anschutz%2C+along+with+UCHealth+and+Children%E2%80%99s+Hospital+Colorado%2C+Form+Strategic+Alliance+with+Bayer+to+Advance+Drug+Development+and+Clinical+Trials/26740099.html <p class="bwalignc"> <i>Bayer’s first academic medical center alliance for clinical trial collaboration is designed to accelerate medical discovery and expand patient access to investigational therapies</i> </p> <p> AURORA, Colo. &amp; WHIPPANY, N.J.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.bayer.com%2Fen%2Fpharma%2Fpharmaceuticals&amp;esheet=54565969&amp;newsitemid=20260707806251&amp;lan=en-US&amp;anchor=Bayer&amp;index=1&amp;md5=3c554759b84e4a37c31cb48405b42861" shape="rect">Bayer</a>, a global life sciences company, has announced a new strategic alliance focused on clinical trials collaboration with <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.cuanschutz.edu%2F&amp;esheet=54565969&amp;newsitemid=20260707806251&amp;lan=en-US&amp;anchor=the+University+of+Colorado+Anschutz&amp;index=2&amp;md5=28722d154de42e09ce8031fd0f123770" shape="rect">the University of Colorado Anschutz</a>, <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.uchealth.org%2F&amp;esheet=54565969&amp;newsitemid=20260707806251&amp;lan=en-US&amp;anchor=UCHealth&amp;index=3&amp;md5=2fcb1924a5e4a4bc281123641aa916f4" shape="rect">UCHealth</a> and <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.childrenscolorado.org%2F&amp;esheet=54565969&amp;newsitemid=20260707806251&amp;lan=en-US&amp;anchor=Children%26%238217%3Bs+Hospital+Colorado&amp;index=4&amp;md5=e2511c6928cd7c67f5eb64ed32077251" shape="rect">Children’s Hospital Colorado</a>, establishing Bayer’s first alliance of its kind with an academic medical center. The initiative reflects a shared commitment to accelerating clinical research through stronger http://www.streetinsider.com/Press+Releases/The+University+of+Colorado+Anschutz%2C+along+with+UCHealth+and+Children%E2%80%99s+Hospital+Colorado%2C+Form+Strategic+Alliance+with+Bayer+to+Advance+Drug+Development+and+Clinical+Trials/26740099.html Tue, 07 Jul 2026 10:00:00 -0400 A.31723490 A.41160441 BAYN BAYN BAYRY BAYZF O.00181262 O.00258640 O.52999085 http://www.streetinsider.com/Press+Releases/The+University+of+Colorado+Anschutz%2C+along+with+UCHealth+and+Children%E2%80%99s+Hospital+Colorado%2C+Form+Strategic+Alliance+with+Bayer+to+Advance+Drug+Development+and+Clinical+Trials/26740099.html <p class="bwalignc"> <i>Bayer’s first academic medical center alliance for clinical trial collaboration is designed to accelerate medical discovery and expand patient access to investigational therapies</i> </p> <p> AURORA, Colo. &amp; WHIPPANY, N.J.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.bayer.com%2Fen%2Fpharma%2Fpharmaceuticals&amp;esheet=54565969&amp;newsitemid=20260707806251&amp;lan=en-US&amp;anchor=Bayer&amp;index=1&amp;md5=3c554759b84e4a37c31cb48405b42861" shape="rect">Bayer</a>, a global life sciences company, has announced a new strategic alliance focused on clinical trials collaboration with <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.cuanschutz.edu%2F&amp;esheet=54565969&amp;newsitemid=20260707806251&amp;lan=en-US&amp;anchor=the+University+of+Colorado+Anschutz&amp;index=2&amp;md5=28722d154de42e09ce8031fd0f123770" shape="rect">the University of Colorado Anschutz</a>, <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.uchealth.org%2F&amp;esheet=54565969&amp;newsitemid=20260707806251&amp;lan=en-US&amp;anchor=UCHealth&amp;index=3&amp;md5=2fcb1924a5e4a4bc281123641aa916f4" shape="rect">UCHealth</a> and <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.childrenscolorado.org%2F&amp;esheet=54565969&amp;newsitemid=20260707806251&amp;lan=en-US&amp;anchor=Children%26%238217%3Bs+Hospital+Colorado&amp;index=4&amp;md5=e2511c6928cd7c67f5eb64ed32077251" shape="rect">Children’s Hospital Colorado</a>, establishing Bayer’s first alliance of its kind with an academic medical center. The initiative reflects a shared commitment to accelerating clinical research through stronger http://www.streetinsider.com/Press+Releases/The+University+of+Colorado+Anschutz%2C+along+with+UCHealth+and+Children%E2%80%99s+Hospital+Colorado%2C+Form+Strategic+Alliance+with+Bayer+to+Advance+Drug+Development+and+Clinical+Trials/26740099.html Tue, 07 Jul 2026 10:00:00 -0400 A.31723490 A.41160441 BAYN BAYN BAYRY BAYZF O.00181262 O.00258640 O.52999085 http://www.streetinsider.com/Press+Releases/The+University+of+Colorado+Anschutz%2C+along+with+UCHealth+and+Children%E2%80%99s+Hospital+Colorado%2C+Form+Strategic+Alliance+with+Bayer+to+Advance+Drug+Development+and+Clinical+Trials/26740099.html <p class="bwalignc"> <i>Bayer’s first academic medical center alliance for clinical trial collaboration is designed to accelerate medical discovery and expand patient access to investigational therapies</i> </p> <p> AURORA, Colo. &amp; WHIPPANY, N.J.--(BUSINESS WIRE)-- <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.bayer.com%2Fen%2Fpharma%2Fpharmaceuticals&amp;esheet=54565969&amp;newsitemid=20260707806251&amp;lan=en-US&amp;anchor=Bayer&amp;index=1&amp;md5=3c554759b84e4a37c31cb48405b42861" shape="rect">Bayer</a>, a global life sciences company, has announced a new strategic alliance focused on clinical trials collaboration with <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.cuanschutz.edu%2F&amp;esheet=54565969&amp;newsitemid=20260707806251&amp;lan=en-US&amp;anchor=the+University+of+Colorado+Anschutz&amp;index=2&amp;md5=28722d154de42e09ce8031fd0f123770" shape="rect">the University of Colorado Anschutz</a>, <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.uchealth.org%2F&amp;esheet=54565969&amp;newsitemid=20260707806251&amp;lan=en-US&amp;anchor=UCHealth&amp;index=3&amp;md5=2fcb1924a5e4a4bc281123641aa916f4" shape="rect">UCHealth</a> and <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.childrenscolorado.org%2F&amp;esheet=54565969&amp;newsitemid=20260707806251&amp;lan=en-US&amp;anchor=Children%26%238217%3Bs+Hospital+Colorado&amp;index=4&amp;md5=e2511c6928cd7c67f5eb64ed32077251" shape="rect">Children’s Hospital Colorado</a>, establishing Bayer’s first alliance of its kind with an academic medical center. The initiative reflects a shared commitment to accelerating clinical research through stronger http://www.streetinsider.com/Press+Releases/The+University+of+Colorado+Anschutz%2C+along+with+UCHealth+and+Children%E2%80%99s+Hospital+Colorado%2C+Form+Strategic+Alliance+with+Bayer+to+Advance+Drug+Development+and+Clinical+Trials/26740099.html Tue, 07 Jul 2026 10:00:00 -0400 A.31723490 A.41160441 BAYN BAYN BAYRY BAYZF O.00181262 O.00258640 O.52999085